Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Salbutamol Sulfate Inhalation Solution

Approval Number

国药准字H20243310

Company立生医药（苏州）有限公司

Registration Date

March 5, 2024

Drug Information

Generic Name

吸入用硫酸沙丁胺醇溶液

Dosage Form

吸入制剂

Strength

2.5ml：5mg（按C₁₃H₂₁NO₃计）

Drug Type

化学药品

Registration Date

March 5, 2024

Company Information

Applicant Company

Company Name立生医药（苏州）有限公司

Company Address

苏州工业园区桑田街218号生物医药产业园二期11号楼

Manufacturing Company

Company Name立生医药（苏州）有限公司

Company Address

苏州工业园区桑田街218号生物医药产业园二期11号楼

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy